Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2020-01-15
Product name
BRILINTA TABLETS
Product Synonyms
Ticagrelor Tablets
1.2.1 Relevant identified uses
Platelet aggregation inhibitor
supplier name
ASTRAZENECA PTY LTD
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
2.1 Classification of the substance or mixture
Short-term (acute) aquatic Category 2 Long-term (chronic) aquatic Category 2
Signal word
None
Hazard statements
H411 Toxic to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment.
Response
P391 Collect spillage.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
May cause dizziness, headache, abdominal pain, dyspepsia, constipation and anxiety. Risk of hypersensitivity reactions in susceptible individuals. See Section 11. May form explosible dust-air mixture if dispersed.
